$0.59 0.00 (0%)
5/28/2009 3:37 PM

Avalon Pharmaceuticals, Inc. (NASDAQ:AVRX)

CAPS Rating: No stars

A biopharmaceutical company which is focused on the discovery and development of potential first-in-class cancer therapeutics.

No players have picked AVRX yet. Tell us why you think AVRX will outperform or underperform the S&P 500.

Featured Broker Partners